These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8022107)

  • 1. Correlations of C1q- and C3d-bearing circulating immune complexes with immunopathological disease activity in lupus nephritis patients.
    Muso E; Yashiro M; Ito Y; Yoshida H; Sasayama S
    Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):345-54. PubMed ID: 8022107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevated levels of circulating immune complexes -C3d and-C1q as a criterion for acute extraintestinal manifestations of ulcerative colitis].
    Sagynbaeva VÉ; Lazebnik LB
    Eksp Klin Gastroenterol; 2014; (7):18-24. PubMed ID: 25842401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
    Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
    J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
    Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
    J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
    Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH
    Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current situation and problems in the estimation of circulating immune complexes].
    Yoshida H
    Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
    Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
    Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.